Antibiotic

In a trial of 1,260 people with irritable bowel syndrome but no constipation, 40 percent given two weeks of rifaximin reported relief against 32 percent of the untreated, and the benefit lasted only 10 weeks. A separate trial found 59 percent improved on a sugar pill.